Literature DB >> 21051972

Pathologic analysis of ex vivo plasma energy tumor destruction in patients with ovarian or peritoneal cancer.

Yukio Sonoda1, Narciso Olvera, Dennis S Chi, Carol L Brown, Nadeem R Abu-Rustum, Douglas A Levine.   

Abstract

INTRODUCTION: Cytoreduction of all visible disease has been associated with improved survival in patients with advanced-stage ovarian or peritoneal cancer. This is best achieved by minimizing injury to normal tissues. We report on the tumor destruction potential, in an ex vivo model, of a novel energy source that uses an electrically neutral beam of pure plasma to vaporize tissue.
METHODS: Tumors were harvested from patients undergoing primary surgical cytoreduction for ovarian or peritoneal cancer. Specimens were divided into 1-cm sections and treated with pure plasma energy for 2 or 4 seconds using standardized power settings. Bright-field microscopy was used to measure the depth of tissue vaporization and lateral thermal damage (LTD).
RESULTS: The mean (SD) tissue vaporization depth was 2.7 (1.3) mm (n = 96). Lateral thermal damage was minimal at all tissue interaction settings (0.13 [0.031] mm). Lateral thermal damage was approximately 5% of the depth of tissue vaporization. Tissue interaction time was a more powerful predictor of vaporization than power. When tissue interaction time increased from 2 to 4 seconds, depth of vaporization and LTD increased by 1.7 and 0.03 mm, respectively (P < 0.001 for both). When power was increased from low to high settings, depth of vaporization increased by 0.6 mm (P = 0.02), and LTD did not change.
CONCLUSIONS: Plasma energy can effectively vaporize ovarian and peritoneal cancer cells. Greater power and tissue interaction time results in more tumor vaporization while maintaining minimal LTD. This is an attractive characteristic of plasma energy that may be useful for eradicating tumor from visceral surfaces.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21051972     DOI: 10.1111/IGC.0b013e3181f3bf04

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  3 in total

1.  A Comparison of Thermal Plasma Energy Versus Argon Beam Coagulator-Induced Intestinal Injury After Vaporization in a Porcine Model.

Authors:  Edward J Tanner; Erica Dun; Yukio Sonoda; Alexander B Olawaiye; Dennis S Chi
Journal:  Int J Gynecol Cancer       Date:  2017-01       Impact factor: 3.437

2.  Video-assisted thoracoscopic PlasmaJet ablation for malignant pleural mesothelioma.

Authors:  Periklis Perikleous; Nizar Asadi; Vladimir Anikin
Journal:  J Vis Surg       Date:  2018-03-20

3.  Application of J-Plasma in the excision of diaphragmatic lesions as part of complete cytoreduction in patients with advanced ovarian cancer.

Authors:  Vasilios Theodoulidis; Anastasia Prodromidou; Emmanouil Stamatakis; Nicholas Alexakis; Alexandros Rodolakis; Dimitrios Haidopoulos
Journal:  Mol Clin Oncol       Date:  2022-05-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.